Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns.

MLA

Violari, Avy, et al. “Safety and Implementation of a Phase 1 Randomized GLA-SE-Adjuvanted CH505TF Gp120 HIV Vaccine Trial in Newborns.” MedRxiv : The Preprint Server for Health Sciences, Oct. 2024. EBSCOhost, https://doi.org/10.1101/2024.10.15.24315548.

APA

Violari, A., Otwombe, K., Hahn, W., Chen, S., Josipovic, D., Baba, V., Angelidou, A., Smolen, K. K., Levy, O., Mkhize, N. N., Woodward, A. S., Martin, T. M., Haynes, B., Williams, W. B., Sagawa, Z. K., Kublin, J., Polakowski, L., Isaacs, M. B., Yen, C., … Gray, G. (2024). Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns. MedRxiv : The Preprint Server for Health Sciences. https://doi.org/10.1101/2024.10.15.24315548

Chicago

Violari, Avy, Kennedy Otwombe, William Hahn, Shiyu Chen, Deirdre Josipovic, Vuyelwa Baba, Asimenia Angelidou, et al. 2024. “Safety and Implementation of a Phase 1 Randomized GLA-SE-Adjuvanted CH505TF Gp120 HIV Vaccine Trial in Newborns.” MedRxiv : The Preprint Server for Health Sciences, October. doi:10.1101/2024.10.15.24315548.